 | Albireo Pharma Inc (ALBO) Expected to Post Q2 2019 Earnings of ($1.42) Per Share
www.americanbankingnews.com - May 16 at 7:57 AM |
| Financial Survey: Takeda Pharmaceutical (TKPYY) versus Albireo Pharma (ALBO)
www.americanbankingnews.com - May 15 at 8:31 AM |
| Albireo Pharma (ALBO) Receives Outperform Rating from William Blair
www.americanbankingnews.com - May 14 at 7:59 AM |
| Albireo Pharma (ALBO) Releases Quarterly Earnings Results, Misses Estimates By $0.02 EPS
www.americanbankingnews.com - May 10 at 1:41 PM |
 | Albireo Pharma, Inc. (ALBO) Q1 2019 Earnings Call Transcript
finance.yahoo.com - May 10 at 9:38 AM |
 | Albireo And Elobixibat In NASH, And The Market Assessment
seekingalpha.com - May 9 at 6:22 PM |
 | Albireo Reports First Quarter 2019 Financial Results
www.globenewswire.com - May 9 at 9:37 AM |
| -$1.37 Earnings Per Share Expected for Albireo Pharma Inc (ALBO) This Quarter
www.americanbankingnews.com - May 7 at 5:50 AM |
| Albireo Pharma Inc (ALBO) Expected to Announce Quarterly Sales of $1.20 Million
www.americanbankingnews.com - May 6 at 1:02 AM |
| Albireo Pharma (ALBO) Set to Announce Earnings on Thursday
www.americanbankingnews.com - May 3 at 9:58 AM |
| Albireo Pharma Inc (ALBO) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - May 3 at 4:42 AM |
 | Albireo to Report First Quarter 2019 Financial Results and Host Conference Call and Webcast
www.nasdaq.com - May 2 at 9:41 AM |
| Albireo to Report First Quarter 2019 Financial Results and Host Conference Call and Webcast
finance.yahoo.com - May 2 at 9:41 AM |
| Albireo's A4250 shows positive action in mid-stage pediatric cholestasis study
seekingalpha.com - April 15 at 6:10 PM |
| Albireo Presents Data on A4250 in Children with Biliary Atresia and Alagille Syndrome at The International Liver Congress 2019
finance.yahoo.com - April 13 at 11:24 AM |
| FDA clears Albireo's IND for mid-stage trial of elobixibat
seekingalpha.com - April 11 at 10:54 AM |
| Albireo Announces FDA Clearance of IND to Commence Phase 2 Trial of Elobixibat for the Treatment of NAFLD/NASH
finance.yahoo.com - April 11 at 10:54 AM |
| Albireo to Present at Investor Conferences in April
finance.yahoo.com - April 1 at 10:11 AM |
| Albireo to Present Clinical Data on A4250 in Alagille Syndrome and Biliary Atresia at The International Liver Congress™ 2019
finance.yahoo.com - March 27 at 10:01 AM |
| Albireo Expands Executive Leadership Team with Appointment of Pamela Stephenson as Chief Commercial Officer
finance.yahoo.com - March 21 at 6:14 PM |
| Avillion Appoints Dr David Chiswell OBE as Board Member
finance.yahoo.com - March 14 at 10:00 AM |
| Albireo Pharma, Inc. (ALBO) CEO Ron Cooper on Q4 2018 Results - Earnings Call Transcript
seekingalpha.com - March 7 at 5:44 PM |
| Albireo Pharma, Inc. (ALBO) Q4 2018 Earnings Conference Call Transcript
finance.yahoo.com - March 7 at 5:44 PM |
| Albireo Reports Year-End 2018 Financial Results and Provides Pipeline Update
finance.yahoo.com - March 7 at 10:13 AM |
| Albireo to Present at Cowen and Company 39th Annual Health Care Conference - GlobeNewswire
globenewswire.com - March 5 at 5:47 PM |
| Albireo to Present at Cowen and Company 39th Annual Health Care Conference
finance.yahoo.com - March 4 at 10:28 AM |
| Albireo Recognizes Rare Disease Day and Highlights Urgent Need to Support Families Affected by Progressive Familial Intrahepatic Cholestasis (PFIC) - GlobeNewswire
globenewswire.com - March 2 at 9:11 AM |
| Albireo Recognizes Rare Disease Day and Highlights Urgent Need to Support Families Affected by Progressive Familial Intrahepatic Cholestasis (PFIC)
finance.yahoo.com - February 28 at 9:40 AM |
| Albireo to Report Year-End 2018 Financial Results and Host Conference Call and Webcast on March 7, 2019
finance.yahoo.com - February 27 at 9:44 AM |
 | Pruritus - Pipeline Insights, 2019 - ResearchAndMarkets.com - Business Wire
www.businesswire.com - February 26 at 5:40 PM |
| Albireo Pharma: Small Pharma With Deep Expertise In Liver Diseases
seekingalpha.com - February 18 at 9:56 AM |
| How Financially Strong Is Albireo Pharma, Inc. (NASDAQ:ALBO)?
finance.yahoo.com - February 7 at 5:30 PM |
| Albireo's lead candidate an Orphan Drug in U.S. for rare liver disorder
seekingalpha.com - January 22 at 5:23 PM |
| Albireo Granted Orphan Drug Designation by FDA For Lead Product Candidate A4250 for Treatment of Biliary Atresia
finance.yahoo.com - January 22 at 9:36 AM |
| Is Albireo Pharma, Inc. (ALBO) A Good Stock To Buy?
finance.yahoo.com - December 23 at 9:05 AM |
| Albireo granted Orphan Designation by EC for A4250 for treatment of biliary atresia
seekingalpha.com - December 18 at 9:32 AM |
| Albireo Granted Orphan Designation by European Commission For Lead Product Candidate A4250 for Treatment of Biliary Atresia
finance.yahoo.com - December 18 at 9:32 AM |
| Albireo Pharma net loss widens in Q3
seekingalpha.com - November 13 at 4:29 PM |
| Albireo Pharma, Inc. (ALBO) CEO Ron Cooper on Q3 2018 Results - Earnings Call Transcript
seekingalpha.com - November 13 at 4:29 PM |
| Albireo Reports Third Quarter 2018 Financial Results
finance.yahoo.com - November 13 at 9:06 AM |
| Albireo to Present at Investor Conferences in November
finance.yahoo.com - November 8 at 9:28 AM |
| Albireo to Report Third Quarter 2018 Financial Results and Host Conference Call and Webcast on November 13, 2018
globenewswire.com - November 7 at 9:36 AM |
| Albireo to Report Third Quarter 2018 Financial Results and Host Conference Call and Webcast on November 13, 2018
finance.yahoo.com - November 6 at 9:27 AM |
| Report: Exploring Fundamental Drivers Behind Manulife Financial, Baozun, AstraZeneca, Insight Enterprises, Albireo ...
globenewswire.com - October 26 at 9:41 AM |
| Albireo's A4250 Fast Track'd for rare liver disease
seekingalpha.com - October 17 at 4:14 PM |
| Albireo Granted Orphan Drug Designation For Lead Product Candidate A4250 for Treatment of Alagille Syndrome
globenewswire.com - October 17 at 9:23 AM |
| Albireo Granted Orphan Drug Designation For Lead Product Candidate A4250 for Treatment of Alagille Syndrome
finance.yahoo.com - October 17 at 9:23 AM |
| Albireo Receives FDA Fast Track Designation for A4250
finance.yahoo.com - October 17 at 9:23 AM |
| Albireo Announces Research on Cholestatic Liver Diseases to be Presented at Major North American Liver Meetings
finance.yahoo.com - October 15 at 9:12 AM |
| Albireo appoints Simon Harford as CFO
seekingalpha.com - October 10 at 9:16 AM |
